HANGZHOU TIGERMED CONSULTING CO LTD.

4.00

0.0000

Volume:- -

Turnover:- -

Market Cap:3.45B

PE:74.66

High:4.00

Open:4.00

Low:4.00

Close:4.00

52wk High:4.00

52wk Low:4.00

Shares:861.29M

Float Shares:622.16M

Volume Ratio:0.53

T/O Rate:- -

Dividend:0.04

Dividend Rate:1.05%

EPS(TTM):0.0536

EPS(LYR):0.0643

ROE:3.33%

ROA:1.33%

PB:1.12

PE(LYR):62.19

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Earning Preview: HANGZHOU TIGERMED CONSULTING CO LTD. Q1 revenue expected to decrease by 2.47%, institutional views are cautious

Earnings Agent

·

Apr 20

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HNGZY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HNGZY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HNGZY\",,,,,undefined,":{"symbol":"HNGZY","market":"US","secType":"STK","nameCN":"HANGZHOU TIGERMED CONSULTING CO LTD.","latestPrice":4,"timestamp":1776974400000,"preClose":4,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":622157332,"shares":861293370,"eps":0.053574,"marketStatus":"Pre-Mkt","change":0,"latestTime":"04-23 16:00:00 EDT Delay","open":4,"high":4,"low":4,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.053574,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777037400000},"marketStatusCode":1,"adr":0,"adrRate":1,"exchange":"PINK LIMITED","adjPreClose":4,"volumeRatio":0.5322924815177404},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HNGZY\",,,,,undefined,":{"symbol":"HNGZY","floatShares":622157332,"roa":"1.33%","roe":"3.33%","lyrEps":0.064314,"volumeRatio":0.5322924815177404,"shares":861293370,"dividePrice":0.042,"high":4,"amplitude":0,"preClose":4,"low":4,"week52Low":4,"pbRate":"1.12","psRate":"3.45","week52High":4,"institutionHeld":0,"latestPrice":4,"eps":0.053574,"divideRate":0.0105,"volume":0,"delay":15,"ttmEps":0.053574,"open":4,"prevYearClose":4,"prevWeekClose":4,"prevMonthClose":4,"prevQuarterClose":4,"fiveDayClose":4,"twentyDayClose":4,"sixtyDayClose":4,"earningDate":1777219200000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HNGZY\",params:#limit:5,,,undefined,":[{"date":"2026-04-27","symbol":"HNGZY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777320000000,"name":null,"time":"Post Market","dateTimestamp":1777262400000,"actualEps":null},{"market":"US","date":"2026-03-30","symbol":"HNGZY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"","actualEps":null},{"date":"2025-06-13","symbol":"HNGZY","amount":0.041365,"announcedDate":"2025-06-02","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"HANGZHOU TIGERMED CONSULTING CO LTD.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-08-14"},{"market":"US","date":"2025-03-27","symbol":"HNGZY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-28","symbol":"HNGZY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1724817600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HNGZY\",market:\"US\",,,undefined,":[{"executeDate":"2023-05-25","recordDate":"2023-05-26","paymentDate":null,"value":0.055696,"currency":"USD"},{"executeDate":"2024-06-11","recordDate":"2024-06-11","paymentDate":"2024-08-14","value":0.07984,"currency":"USD"},{"executeDate":"2025-06-13","recordDate":"2025-06-13","paymentDate":"2025-08-14","value":0.041365,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HNGZY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2353,"buy":0.5294,"hold":0.1176,"sell":0.1176,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5294,"analysts":17,"updateTime":1776312000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HNGZY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1117843060","title":"Earning Preview: HANGZHOU TIGERMED CONSULTING CO LTD. Q1 revenue expected to decrease by 2.47%, institutional views are cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=1117843060","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1117843060?lang=en_us&edition=fundamental","pubTime":"2026-04-20 11:57","pubTimestamp":1776657460,"startTime":"0","endTime":"0","summary":"Abstract HANGZHOU TIGERMED CONSULTING CO LTD. will report quarterly results on April 27, 2026 Post Market; this preview outlines revenue, margins, profitability trends, and consensus-style forecasts...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: HANGZHOU TIGERMED CONSULTING CO LTD. Q1 revenue expected to decrease by 2.47%, institutional views are cautious","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HNGZY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/HNGZY\",params:#limit:6,delay:false,,,undefined,":[]}}